These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37052770)

  • 21. A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.
    Van Skike CE; Galvan V
    Gerontology; 2018; 64(3):205-211. PubMed ID: 29320772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease.
    Cassano T; Magini A; Giovagnoli S; Polchi A; Calcagnini S; Pace L; Lavecchia MA; Scuderi C; Bronzuoli MR; Ruggeri L; Gentileschi MP; Romano A; Gaetani S; De Marco F; Emiliani C; Dolcetta D
    Exp Neurol; 2019 Jan; 311():88-105. PubMed ID: 30243986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
    Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
    Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer's disease-like pathology in a mouse model.
    Pupyshev AB; Belichenko VM; Tenditnik MV; Bashirzade AA; Dubrovina NI; Ovsyukova MV; Akopyan AA; Fedoseeva LA; Korolenko TA; Amstislavskaya TG; Tikhonova MA
    Pharmacol Biochem Behav; 2022 Jun; 217():173406. PubMed ID: 35609863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
    Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
    Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease.
    Sun YX; Ji X; Mao X; Xie L; Jia J; Galvan V; Greenberg DA; Jin K
    J Alzheimers Dis; 2014; 38(2):437-44. PubMed ID: 23979023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus.
    Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC
    Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
    Ding Y; Liu H; Cen M; Tao Y; Lai C; Tang Z
    Neurochem Res; 2021 Feb; 46(2):265-275. PubMed ID: 33140268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways.
    Lesniewski LA; Seals DR; Walker AE; Henson GD; Blimline MW; Trott DW; Bosshardt GC; LaRocca TJ; Lawson BR; Zigler MC; Donato AJ
    Aging Cell; 2017 Feb; 16(1):17-26. PubMed ID: 27660040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.
    Yates SC; Zafar A; Hubbard P; Nagy S; Durant S; Bicknell R; Wilcock G; Christie S; Esiri MM; Smith AD; Nagy Z
    Acta Neuropathol Commun; 2013 May; 1():3. PubMed ID: 24252508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer's disease: An in vivo study.
    Khonsari F; Heydari M; Sharifzadeh M; Valizadeh H; Dinarvand R; Atyabi F
    Biomater Adv; 2022 Jun; 137():212827. PubMed ID: 35929260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
    Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
    Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The db mutation improves memory in younger mice in a model of Alzheimer's disease.
    Zhang L; Fernandez-Kim SO; Beckett TL; Niedowicz DM; Kohler K; Dasuri K; Bruce-Keller AJ; Murphy MP; Keller JN
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2157-2167. PubMed ID: 31034991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR signaling and Alzheimer's disease: What we know and where we are?
    Davoody S; Asgari Taei A; Khodabakhsh P; Dargahi L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14463. PubMed ID: 37721413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease.
    Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W
    Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astaxanthin Improved the Cognitive Deficits in APP/PS1 Transgenic Mice Via Selective Activation of mTOR.
    Huang C; Wen C; Yang M; Li A; Fan C; Gan D; Li Q; Zhao J; Zhu L; Lu D
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):609-619. PubMed ID: 32944864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin and mTOR inhibitors probably have therapeutic effects for post-operative cognitive dysfunction.
    Yang C; Zhu B; Shen J; Hu T; Li Z; Hong T
    Med Hypotheses; 2013 Sep; 81(3):487-8. PubMed ID: 23850396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapamycin and Alzheimer's disease: Time for a clinical trial?
    Kaeberlein M; Galvan V
    Sci Transl Med; 2019 Jan; 11(476):. PubMed ID: 30674654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the mTOR signaling network for Alzheimer's disease therapy.
    Wang C; Yu JT; Miao D; Wu ZC; Tan MS; Tan L
    Mol Neurobiol; 2014 Feb; 49(1):120-35. PubMed ID: 23853042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.